BioTeSys GmbH
Esslingen am Neckar, 73728, Germany
NCT Number: NCT04097808
The aim of this study is the comparison of the oral bioavailability of hydroxyproline, a key marker for collagen peptide intake, after ingestion of collagen peptides from different sources, sizes and together with different food matrices, either containing high or low levels of polyphenols.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Esslingen am Neckar, 73728, Germany
The absorption (blood) of collagen peptides from bovine, fish and porcine source in different sizes and administered together with foods of different polyphenol content will be assessed. Pharmacokinetic parameters (AUC0-6h, Cmax and Tmax) after oral single dose administration will be determined to estimate the impact of different sources, different peptide sized any food matrix.
The following objectives will be evaluated exploratory by comparison of pharmacokinetic parameters from the concentration time curve of hydroxyproline, a key marker of collagen type I, between:
Additionally, concentration time curves of further amino acids will be assessed descriptively.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Main Inclusion Criteria:
Main Exclusion Criteria:
Collagen peptides will be orally administered and pharmacokinetic parameters will be assessed up to 6 hours after study product intake.
Time frame: pre dose and up to 6 hours post dose
Pharmakokinetic variable
Time frame: pre dose and up to 6 hours post dose
Pharmakokinetic variable
Time frame: pre dose and up to 6 hours post dose
Pharmakokinetic variable
Time frame: pre dose and up to 6 hours post dose
Rousselot BVBA
Industry
Impact of the Source and Polyphenol-containing Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07345130
Bioavailability, Bioequivalence
Las Vegas, Nevada, United States
View Trial DetailsNCT06481709
Bioavailability
Toronto, Ontario, Canada
View Trial DetailsNCT05263895
Bioavailability, COVID-19
New Haven, Connecticut, United States
View Trial DetailsNCT05627518
Bioavailability, Pharmacokinetics
Ljubljana, Ukmarjeva Ulica 6, Slovenia
View Trial Details